Lifetime GLP-1 agonist use hits 32.1% in eating disorder groups, well above the 15% general rate, with misuse tied to rapid ...
The site is continuing to recommend harmful videos despite new rules meant to better protect teenagers in the UK, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results